Your Search Returned 307 tagged news reports
Ohio's fledgling medical corridor is raising its speed limit. Eight hospital and university systems in Columbus, Cincinnati and Cleveland will announce an agreement today that already has expedited the review process for multicenter research projects.
The 30-person, Phase I study is the first in-human test of AYX-1, the San Francisco company's experimental preventative treatment for post-surgical pain. The study of healthy volunteers is designed to test the drug's safety.
The innovation gallery according to Khened will introduce children to some of the most ground breaking discoveries that changed the course of the world. Think about innovations like the Apple products and creators like Steve Jobs...But apart from big
July 23, 2012 A screenshot of the homepage of the Journal of Visualized Experiments. (The Epoch Times) Research papers have always been regarded as dull and hard to understand, but the Journal of Visualized Experiments (JoVE) has turned things around.
The researchers needed to assume there was such a relationship because there was no way to be sure that some other factor wasn't at playfor instance, some underlying disease that curtailed the lives of survey respondents who sat more. Some of the
India '+google_ads[i].line2 +' '+google_ads[i].line3 + ' The government will be analysing mortality figures during drug trials in India following WHO data showing that 2,031 people died between 2008 and 2011 during such trials in the country. That
Would you pay a fine more promptly if you received a personalised text message reminder? Would you settle your accounts sooner if you got a letter from the taxman saying most people in your area had already paid up? As austerity hits government
Double-Digit Jump Watch stocks you care about The single, easiest way to keep track of all the stocks that matter.....Shares jumped 11% yesterday, and they're up another 8% today...One phase 3 trial success is a good indicator that a drug will pass
Mayo Clinic, has adequate experience and/or patient volume to even begin to perform meaningful research. Still in its infancy, patient-initiated research may prove to be the new gold standard for the study of uncommon medical conditions. The people
This isn't the first misstep the biotech has made releasing data for its combination of VX-809 and Kalydeco to treat cystic fibrosis. When the company reported interim data last month, it presented the data as if it was absolute improvements in lung